Brian Millham - Aug 8, 2022 Form 3 Insider Report for Salesforce, Inc. (CRM)

Signature
/s/ Scott Siamas, Attorney-in-Fact for Brian Millham
Stock symbol
CRM
Transactions as of
Aug 8, 2022
Transactions value $
$0
Form type
3
Date filed
8/17/2022, 07:07 PM
Next filing
Sep 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRM Common Stock 5.72K Aug 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRM Non-qualified Stock Option (Right to Buy) Aug 8, 2022 Common Stock 8.22K $118.04 Direct F1
holding CRM Non-qualified Stock Option (Right to Buy) Aug 8, 2022 Common Stock 6.61K $146.87 Direct F2
holding CRM Non-qualified Stock Option (Right to Buy) Aug 8, 2022 Common Stock 15.4K $161.50 Direct F3
holding CRM Restricted Stock Units Aug 8, 2022 Common Stock 922 $0.00 Direct F4, F5
holding CRM Non-qualified Stock Option (Right to Buy) Aug 8, 2022 Common Stock 54.1K $154.14 Direct F6
holding CRM Restricted Stock Units Aug 8, 2022 Common Stock 4.58K $0.00 Direct F5, F7
holding CRM Non-qualified Stock Option (Right to Buy) Aug 8, 2022 Common Stock 415K $240.95 Direct F8
holding CRM Non-qualified Stock Option (Right to Buy) Aug 8, 2022 Common Stock 96.9K $215.17 Direct F9
holding CRM Restricted Stock Units Aug 8, 2022 Common Stock 18K $0.00 Direct F5, F10
holding CRM Non-qualified Stock Option (Right to Buy) Aug 8, 2022 Common Stock 101K $218.21 Direct F11
holding CRM Restricted Stock Units Aug 8, 2022 Common Stock 27.3K $0.00 Direct F5, F12
holding CRM Performance-Based Restricted Stock Units Aug 8, 2022 Common Stock 12.6K $0.00 Direct F13, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option is exercisable and vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F2 Option is exercisable and vests over four years at the rate of 25% on July 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F3 Option is exercisable and vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F4 These restricted stock units vest as to 25% of the original grant on March 22, 2020 and vest as to 1/16 of the original grant quarterly thereafter.
F5 Restricted stock units convert to shares of Issuer common stock on a one-for-one basis.
F6 Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F7 These restricted stock units vest as to 25% of the original grant on April 22, 2021, and vest as to 1/16 of the original grant quarterly thereafter.
F8 Option is exercisable and vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F9 Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F10 These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter.
F11 Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F12 These restricted stock units vest as to 25% of the original grant on March 22, 2023, and vest as to 1/16 of the original grant quarterly thereafter.
F13 The PRSUs will vest depending on Issuer's total shareholder return ("TSR") over the three-year period from the grant date (the "Performance Period"), relative to companies in the NASDAQ-100 Index as of the grant date (the "Index Group"). If Issuer's TSR over the Performance Period is at the 60th percentile when ranked against the Index Group TSRs, 100% of the target number of shares will vest. For every percentile by which Issuer's TSR ranking within the Index Group exceeds the 60th percentile, shares vesting will increase by 3 and 1/3%, up to a maximum payout of 200% of target if Issuer's TSR ranking is at the 99th percentile. For every percentile by which Issuer's TSR ranking within the Index Group is below the 60th percentile, shares vesting will decrease by 2 and 22/39%, with no payout if Issuer's TSR ranking is below the 30th percentile. If Issuer's absolute TSR over the Performance Period is negative, the number of shares vesting will not exceed 100% of target.
F14 Each performance-based restricted stock unit, or PRSU, represents a contingent right to receive one share of Issuer common stock.

Remarks:

Exhibit 24 - Power of Attorney